Skip to main content
Clinical Trials/NCT03026192
NCT03026192TerminatedNot Applicable

Use of Near Infrared Spectroscopy in Preterm Infants to Determine Patent Ductus Arteriosus Closure Following Medical Treatment

Albany Medical College1 site in 1 country4 target enrollmentStarted: December 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
4
Locations
1
Primary Endpoint
Change in NIRS readings

Study Overview

Brief Summary

Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
1 Minute to 1 Week (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • preterm infants less than 32 weeks gestation

Exclusion Criteria

  • infection, congenital heart disease, syndromic anomalies, and perinatal asphyxia.

Outcomes

Primary Outcomes

Change in NIRS readings

Time Frame: 3 days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kate Tauber

Assistant Professor

Albany Medical College

Study Sites (1)

Loading locations...

Similar Trials

Near Infrared Spectroscopy to Determine... | Clinical Trial